SCHEMBL3673709

SCHEMBL3673709

CN1CCN(C(C(=O)O)c2cccc3c2OCCO3)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
MC4R P32245 1/20 0.39
MTNR1A P48039 4/20 0.39
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
HTR2A P28223 1/20 0.38
DRD3 P35462 1/20 0.38
HTR1A P08908 2/20 0.38
HPGD P15428 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR6 P50406 1/20 0.38
HTR4 Q13639 1/20 0.37
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13044550 0.79 MC4R (0.40) KDM4EMC4RDRD2HTR2AHTR1A
Hydrochloric Acid SCHEMBL3636403 0.78 MC4R (0.39) KDM4EMC4RDRD2HTR2AHTR1A
SCHEMBL3639883 0.76 GHSR (0.68) HTR1AALDH1A1SMN1; SMN2
SCHEMBL3635128 0.74 PTGS1 (0.57) KDM4EHPGDALDH1A1SMN1; SMN2MAPT
SCHEMBL13984355 0.74 MC4R (0.49) KDM4EMC4RDRD1HTR2ADRD3
SCHEMBL13044458 0.73 MC4R (0.54) MC4RDRD1HTR2ADRD3MAPT
SCHEMBL3060888 0.73 KDM4E (0.47) KDM4EMC4RDRD1HTR2ADRD3
SCHEMBL13044412 0.72 MC4R (0.67) MC4RDRD1HTR2ADRD3
Hydrochloric Acid SCHEMBL3639303 0.72 MC4R (0.48) MC4RDRD1HTR2ADRD3ALDH1A1
SCHEMBL13044372 0.72 GHSR (0.55) KDM4EMC4RDRD1HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
EP-2167466-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR Glaxo Group Limited (GB) 2010-03-31 EP disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R KDM4E 2651/4885MC4R 13/4885MTNR1A 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.